Abingworth Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 14

Professionals
  • Investments
  • 249

  • Portfolio
  • 33

  • Exits
  • 156

Exits

Abingworth General Information

Description

Founded in 1973, Abingworth is a venture capital firm headquartered in London, United Kingdom. The firm prefers to invest in seed-stage, early-stage, growth-stage, and later-stage companies. The firm seeks to invest in healthcare, information technology, life science, and technology-based sectors in the United States and Europe.

Contact Information

Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
British Venture Capital Association (BRVCA)
New England Venture Capital Association (NEVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 38 Jermyn Street
  • London SW1Y 6DN
  • England, United Kingdom
+44 020 0000 0000

Abingworth Investments & Acquisitions (249)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Pathalys Pharma 18-Jan-2023 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 3
000000000 06-Dec-2022 00000 00000 0000 Biotechnology Generating Revenue 000000 00000000 00.0
0000000 0000000000 28-Nov-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 000000 0000000 00.0
0000000 18-May-2022 0000 000 Drug Discovery Generating Revenue/Not Profitable 0000 0000000000 00.0
000000 00000000000 11-Apr-2022 00000 000000 Other Healthcare Services Generating Revenue 0000 000 000000
00000000 000000000 04-Apr-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 0000000 000000
00000 000 30-Sep-2021 0000 00000 00.000 Other Commercial Products Stealth
000000 00000000000 24-Sep-2021 0000 00000 Drug Discovery Clinical Trials - Phase 1 0000 000 000000
Anjarium Biosciences 16-Sep-2021 Later Stage VC 000.00 Drug Delivery Generating Revenue 0000 0000000000 00.0
HilleVax 08-Sep-2021 Early Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable
You’re viewing 10 of 249 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abingworth Exits (156)

Company Name Exit Date Exit Type Exit Size
Sierra Oncology 01-Jul-2022 Merger/Acquisition 00.00
00000000 29-Apr-2022 000 00000
0000 000000000000 11-Feb-2022 000000 0000000000 000.00
00000000 000000000 10-Jan-2022 000000000000000000
0000000000 0000000 27-Oct-2021 000000000000000000
000000 00000000000 24-Sep-2021 000000000000000000 00000
00000 0000 0000000 22-Sep-2021 0000000 000000 00000
00000000 000000000 26-Aug-2021 0000000 000000 00000
Avillion 01-Jul-2021 Secondary Transaction - Private
Vera Therapeutics 14-May-2021 IPO 000.00
You’re viewing 10 of 156 exits. Get the full list »

Abingworth Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Abingworth‘s full profile, request access.

Request a free trial

Abingworth Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Abingworth Team (50)

Name Title Deals Funds Boards Office
Neil Cooper Chief Financial Officer London, United Kingdom
Andrew Sinclair Ph.D Managing Director 0 0 0 London, United Kingdom
Jayson Punwani Ph.D Managing Director 0 0 0 London, United Kingdom
Joy Ghosh Ph.D Managing Director 0 0 London, United Kingdom
Kurt von Emster Managing Partner 00 0 0 Menlo Park, CA
You’re viewing 5 of 50 team members. Get the full list »

Abingworth Co-Investors (118)

Name With Exits Lead Partner Series Industry
Citadel Enterprise Americas 5 0 Series chart Industry bar
Osage University Partners 0 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 0 Series chart Industry bar
Omega Funds 0 0 Series chart Industry bar
RiverVest Venture Partners 0 0 Series chart Industry bar
You’re viewing 5 of 118 co-investors. Get the full list »